| Literature DB >> 34959336 |
Jeyson Hermosilla1,2, Edgar Pastene-Navarrete2, Francisca Acevedo3,4.
Abstract
Burns are a major threat to public health and the economy due to their costly and laborious treatment and high susceptibility to infection. Efforts have been made recently to investigate natural bioactive compounds with potential use in wound healing. The importance lies in the capacities that these compounds could possess both in infection control by common and resistant microorganisms, as well as in the regeneration of the affected tissues, having in both cases low adverse effects. However, some bioactive molecules are chemically unstable, poorly soluble, and susceptible to oxidative degradation or have low bioavailability. Therefore, developing new technologies for an efficient treatment of wound healing poses a real challenge. In this context, electrospun nanofibers have gained increasing research interest because bioactive molecules can be easily loaded within the nanofiber, resulting in optimal burst control and enhanced drug stability. Additionally, the nanofibers can mimic the extracellular collagen matrix, providing a suitable highly porous structural support for growing cells that facilitate and accelerate skin burns healing. This review gives an overview of the current state of electrospun fibers loaded with natural bioactive compounds as a biomedical system for skin burn treatment.Entities:
Keywords: antimicrobial agents; biomaterials; electrospinning; wound healing
Year: 2021 PMID: 34959336 PMCID: PMC8707873 DOI: 10.3390/pharmaceutics13122054
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.321
Synthetic bioactive and/or non-biological compounds reported in the literature.
| Active Compound | Reference | |
|---|---|---|
| Metallic Particles | Silver Nitrate | [ |
| Silver NanoparticlesSilver Nitrate | [ | |
| Mesoporous Silica Nanoparticles with Silver Nanoparticles | [ | |
| Zinc Oxide Nanoparticles | [ | |
| Iron oxide Nanoparticles | [ | |
| Gold Nanoparticles | [ | |
| Piroxicam | [ | |
| Synthetic compounds | Nitrofurazone | [ |
| Cefotaxime | [ | |
| Hydroxyapatite | [ | |
| Silver Sulfadiazine | [ | |
| Peptide P12 | [ | |
| Polycaprolactone | [ | |
| Polypropylene Fumarate | [ | |
| Mineralized Magnesium | [ | |
Figure 1(A) Schematic representation of an electrospinning apparatus, showing the formation of the Taylor’s cone. Figure from Luraghi et al. [46] with permission from Elsevier. (B) Electrospun fiber formation.
Figure 2SEM images of the electrospun fiber mats from (a) the base gelatin solution and (b) the AgNO3-containing gelatin solution that had been aged for 12 h. Figure from Rujitanaroj et al. [27] Copyright (2021), with permission from Elsevier.
Characteristics of electrospun fibers with intended biological effects from 24 articles reviewed.
| Matrix | Encapsulated | Electrospinning | Diameter of | Fiber | Biological | Reference |
|---|---|---|---|---|---|---|
| Polyurethane | Badger | Voltage: 20 kV | 375–518 nm | Blend-composite | Antibacterial | [ |
| Polyurethane/Silver nanoparticles | Olive Oil ( | Voltage: 15 kV | 250–550 nm | Blend-composite | Antibacterial | [ |
| Silk fibroin/Gelatin | Astragaloside IV | Voltage: 15 kV | _ | Blend-composite | Accelerate the process of wound healing | [ |
| Chitosan-Deacetylated | Chitosan/L-arginine | Voltage: 28 kV | 50–500 nm | Blend-composite | Antibacterial | [ |
| Polycaprolactone/Gelatin (Core) | Minocycline hydrochloride | Voltage: 13 kV | 300–450 nm | Core/Shell | Antibacterial Nanofibers | [ |
| Polylactide/Collagen | Fermented rooibos | Voltage: 25 kV | 13–23 µm | Blend-composite | Antibacterial Nanofibers; | [ |
| Bromelain | Voltage: 10 kV | 140–360 nm | Blend-composite | Accelerate the | [ | |
| Polylactide/Poly(ethylene glycol) (Core) | Peptides HHC36 | Voltage: 20 kV | 3.2–4.6 μm | Core/Shell | Antibacterial | [ |
| Gelatin | ε-Polylysine | Voltage: 12 kV | 425 ± 33 nm | Blend-composite | Antibacterial | [ |
| Poly(vinyl alco-hol) | Chitosan | Voltage: 18 kV | 130–170 nm | Blend-composite | Antibacterial | [ |
| Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) | _ | Voltage: 8 kV | 510–670 nm | Simple Fibers (Mono-polymer) | Accelerate the | [ |
| Silk fibroin/Poloxamer 407 (P407) | Manuka | Voltage: 25–23 kV | 2.4–5.9 μm | Blend-composite | Antibacterial; | [ |
| Sodium Alginate-Poly(ethylene glycol)/Pluronic F127 (surfactant) | Lavender essential oil | Voltage: 25 kV | 50–125 nm | Blend-Emulsion Electrospinning | Antibacterial Nanofibers; | [ |
| Polycaprolactone/Chitosan | Quercetin/Rutin | Voltage: 24–32 kV | 90–120 nm | Blend-composite | Antibacterial Nanofibers; | [ |
| Chitosan/Poly(ethylene oxide) | Actinidin | Voltage:—kV | 100–200 nm | Blend-composite + | Antibacterial Nanofibers; | [ |
| Gelatin (layer 1) | Fibrin | Voltage: 25–30 kV | 150–350 nm | Blend-composite | Antibacterial Nanofibers; | [ |
| Polycaprolactone | α-Lactalbumin | Voltage: 9–18 kV | 183–344 nm | Blend-composite | Accelerate the process of wound healing | [ |
| Poly(vinyl pyrrolidone)/Keratin | Cinnamon essential oil | Voltage: 24 kV | 315–466 nm | Blend-composite | Antibacterial Nanofibers; | [ |
| Polycaprolactone/Gelatin | Plant extracts: | Voltage: 15 kV | 266–601 nm | Blend-composite | Accelerate the | [ |
| Poly-D,L-lactic acid | Microalga Spirulina ( | Voltage: 15 kV | 260–270 nm | Blend-composite | Accelerate the | [ |
| Poly(L-lactic acid)/polyhedral oligomeric silsesquioxane nanoparticles | Plasmid DNA Encoding Angiopoietin-1 (pAng) | Voltage: 13 kV | 580–780 nm | Blend-composite | Accelerate the | [ |
| Polycaprolactone/Collagen | _ | Voltage: 13 kV | 170–275 nm | Blend-composite | Accelerate the | [ |
| Poly(lactic-co-glycolic acids)/Collagen | _ | Voltage: 28 kV | 100–300 nm | Blend-composite | Accelerate the | [ |
| Polycaprolactone (12.5% | Curcumin | Voltage: 12, 18, 24 kV | _ | Blend-composite | Antibacterial | [ |
Figure 3Types of electrospun fiber: (a) simple; (b) blend; (c) core-shell.
Materials used for the production of electrospun fibers in 24 articles reviewed.
| Material Type | Material Name | Reference |
|---|---|---|
| Natural | Chitosan | [ |
| Collagen | [ | |
| Gelatin | [ | |
| Keratin | [ | |
| Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) | [ | |
| Silk Fibroin | [ | |
| Sodium Alginate | [ | |
| Synthetic | Poly(ethylene glycol)/Poly(ethylene oxide)/Polyoxyethylene | [ |
| Poly(lactic-co-glycolic acids) | [ | |
| Poly(L-lactic acid) | [ | |
| Poly(vinyl alcohol) | [ | |
| Poly(vinyl pyrrolidone) | [ | |
| Polycaprolactone | [ | |
| Poly-D,L-lactic acid | [ | |
| Polylactide | [ | |
| Polyurethane | [ |
Natural bioactive compounds with antimicrobial properties and/or which accelerate burn wound healing loaded in electrospun fibers.
| Biological Effects | Bioactive Compounds | Reference |
|---|---|---|
| Antimicrobial | Badger | [ |
| Olive ( | [ | |
| CH—CH/L-arginine | [ | |
| [ | ||
| ε-Polylysine | [ | |
| Manuka Honey (*) | [ | |
| Peptides HHC36 | [ | |
| Curcumin | [ | |
| Wound healing accelerator | Astragaloside IV | [ |
| Bromelain | [ | |
| Quercetin/Rutin | [ | |
| Actinidin | [ | |
| Fibrin | [ | |
| α-Lactalbumin | [ | |
| Microalga Spirulina ( | [ | |
| Plasmid DNA Encoding Angiopoietin-1 | [ | |
| Antimicrobial and wound healing accelerator | [ | |
| Lavender | [ | |
| Cinnamon ( | [ | |
| [ | ||
| [ | ||
| [ | ||
| [ |
(*) Used in the study for its hygroscopic capacities, not for its antimicrobial activity.